Real-World Evaluation of GLP-1 Receptor Agonist Therapy Persistence, Adherence and Therapeutic Inertia Among Obese Adults with Type 2 Diabetes
2023 · Diabetes Therapy · 37 citations
https://doi.org/10.1007/s13300-023-01382-9
J
José Miguel Calderón
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
17
Papers
134
Citations
6
h-index
4
i10-index
José Miguel Calderón is an academic researcher from Universitat de València. The author has contributed to research in topics: Blood Pressure and Hypertension Studies & Atrial Fibrillation Management and Outcomes & Long-Term Effects of COVID-19. The author has an h-index of 6, co-authored 15 publications.
ORCID: 0000-0003-3280-9114Papers by this author
worksReal world data of anticoagulant treatment in non-valvular atrial fibrillation across renal function status
2022 · Scientific Reports · 4 citations
https://doi.org/10.1038/s41598-022-10164-5
Comparison of GLP-1 receptor agonists and other Glucose-Lowering agents on cardiovascular outcomes in individuals with type 2 diabetes and Obesity: A Spanish Real-World Population-Based study
2023 · Diabetes Research and Clinical Practice · 3 citations
https://doi.org/10.1016/j.diabres.2023.111071
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat